Slingshot members are tracking this event:

European Commission Grants Marketing Authorization for Gilead’s Once-Daily Truvada For Reducing the Risk of Sexually Acquired HIV-1

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks

Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 22, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Sexually Acquired Hiv, Marketing Authorization, Truvada, Pre-exposure Prophylaxis